Verity Asset Management’s AbbVie ABBV Stock Holding History

Verity Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$617K	Buy	2,838 +20	+0.7%	+$4.44K	0.26%	107
2025 Q4	$644K	Buy	2,818 +156	+6%	+$35.5K	0.28%	103
2025 Q3	$616K	Sell	2,662 -2	-0.1%	-$407	0.2%	113
2025 Q2	$494K	Buy	2,664 +305	+13%	+$56.7K	0.24%	108
2025 Q1	$494K	Buy	2,359 +261	+12%	+$50.7K	0.2%	115
2024 Q4	$360K	Buy	2,098 +344	+20%	+$63.2K	0.2%	111
2024 Q3	$347K	Buy	1,754 +116	+7%	+$21.6K	0.13%	141
2024 Q2	$281K	Buy	1,638 +148	+10%	+$24.5K	0.11%	152
2024 Q1	$271K	Sell	1,490 -1	-0.1%	-$172	0.15%	156
2023 Q4	$231K	Buy	+1,491	New	+$217K	0.15%	161

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verity Asset Management's ABBV Position: Q1 2026 in Review

Verity Asset Management increased its AbbVie (ABBV) stake by 0.71% in Q1 2026, buying an estimated $4.44K and bringing the position to 2,838 shares worth $617K. The position accounts for 0.26% of the portfolio, ranked #107.

Verity Asset Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $644K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Verity Asset Management held 2,838 shares of AbbVie worth $617K as of Q1 2026.
Verity Asset Management bought 20 AbbVie shares in Q1 2026, an estimated $4.44K.
AbbVie made up 0.26% of Verity Asset Management's portfolio in Q1 2026, its #107 holding.
Verity Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Verity Asset Management's AbbVie position peaked at $644K in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.